GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sinohealth Holdings Ltd (HKSE:02361) » Definitions » Shares Outstanding (EOP)

Sinohealth Holdings (HKSE:02361) Shares Outstanding (EOP) : 409.1 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sinohealth Holdings Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Sinohealth Holdings's shares outstanding for the quarter that ended in Jun. 2024 was 409.1 Mil.

Sinohealth Holdings's quarterly shares outstanding declined from Dec. 2023 (415.0 Mil) to Jun. 2024 (409.1 Mil). It means Sinohealth Holdings bought back shares from Dec. 2023 to Jun. 2024 .

Sinohealth Holdings's annual shares outstanding declined from Dec. 2022 (431.2 Mil) to Dec. 2023 (415.0 Mil). It means Sinohealth Holdings bought back shares from Dec. 2022 to Dec. 2023 .


Sinohealth Holdings Shares Outstanding (EOP) Historical Data

The historical data trend for Sinohealth Holdings's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinohealth Holdings Shares Outstanding (EOP) Chart

Sinohealth Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
450.00 450.00 373.12 431.19 414.96

Sinohealth Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only 450.00 431.19 430.02 414.96 409.08

Competitive Comparison of Sinohealth Holdings's Shares Outstanding (EOP)

For the Health Information Services subindustry, Sinohealth Holdings's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinohealth Holdings's Shares Outstanding (EOP) Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sinohealth Holdings's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Sinohealth Holdings's Shares Outstanding (EOP) falls into.



Sinohealth Holdings Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Sinohealth Holdings  (HKSE:02361) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Sinohealth Holdings Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Sinohealth Holdings's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinohealth Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Wangjiang Second Street, Room 1111, Huangge Town, Nansha District, Guangdong Province, Guangzhou City, CHN
Sinohealth is a leading provider of Big Data and artificial intelligence-based marketing and distribution information tools, including SaaS-based customer relationship management solutions to mainland China medical product manufacturers. It sources retail data through pharmacy partnerships and provides data analysis to the pharmaceutical and corporate clients it serves. Since its establishment in 2007, its focus has been on building a strong Big Data engine and networking capabilities to assist clients in their product investments and sales and marketing strategies. It is now launching various cloud-based systems and platform solutions for its clients and expanding its SaaS products, which are expected to be the key growth driver in future.
Executives
Futu Trustee Limited 2301 Trustee
Shanghai Tianyi Assets Management Co., Ltd 2201 Interest of corporation controlled by you
Yu Rong 2201 Interest of corporation controlled by you
Tianyi (bvi) Limited 2101 Beneficial owner
Shang Hai Xuan Yu Qi Ye Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Rikan Industry Investment Limited Partnership
Wang Lifang 2201 Interest of corporation controlled by you
Wu Yushu 2201 Interest of corporation controlled by you
Wlf Investment Holdings Limited 2101 Beneficial owner
Li Hanxiong 2201 Interest of corporation controlled by you
Montesy Capital Holding Ltd 2101 Beneficial owner
Wu Meirong 2202 Interest of your spouse
Ying Lian You Xian Gong Si 2101 Beneficial owner

Sinohealth Holdings Headlines

No Headlines